Clinical Trial Update: Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 non-inferiority study comparing Noex 50µg to Busonid 50µg for allergic rhinitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis

Drugs mentioned

• Busonid (budesonide)
• Noex (unknown)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: WITHDRAWN